Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG ... enhance procedural efficiency and improve patient outcomes for interventional procedures – bringing better care to more people.

Nick shares his insights on the pressing challenges facing the U.S. healthcare market and how Philips is transforming patient care through advanced data analytics, diagnostics, and remote monitoring.

Dutch medtech giant Philips has announced that it has enrolled the first patient in its THOR IDE clinical trial set to study the company’s combined laser atherectomy and intravascular ...

It also showcases how this innovative new technology, which resulted from Philips’ powerful in-house development capabilities, can ease the patient experience by streamlining complex ...

November 12, 2024Designed specifically for use in radiation oncology, new Spectral CT 7500 RT enables personalized radiation therapy planning to ...

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a ...

Philips' patient- and people-centric innovation leverages advanced ... ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 ...

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease GlobeNewswire November 04, 2024 With a unique world-first ability to ...